These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 9551083)
1. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA). Balzarini J; Hatse S; Naesens L; De Clercq E Biochim Biophys Acta; 1998 Mar; 1402(1):29-38. PubMed ID: 9551083 [TBL] [Abstract][Full Text] [Related]
2. N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties. Hatse S; Naesens L; De Clercq E; Balzarini J Biochem Pharmacol; 1999 Jul; 58(2):311-23. PubMed ID: 10423173 [TBL] [Abstract][Full Text] [Related]
3. Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line. Hatse S; De Clercq E; Balzarini J Mol Pharmacol; 1998 Nov; 54(5):907-17. PubMed ID: 9804626 [TBL] [Abstract][Full Text] [Related]
4. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent. Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049 [TBL] [Abstract][Full Text] [Related]
5. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells. Hatse S; De Clercq E; Balzarini J Mol Pharmacol; 1996 Nov; 50(5):1231-42. PubMed ID: 8913355 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts. Merta A; Veselý J; Votruba I; Rosenberg I; Holý A Neoplasma; 1990; 37(2):111-20. PubMed ID: 2160620 [TBL] [Abstract][Full Text] [Related]
7. The cytostatic effects and mechanism of action of antiviral acyclic adenine nucleotide analogs in L1210 mouse leukemia cells. Veselý J; Merta A; Votruba I; Rosenberg I; Holý A Neoplasma; 1990; 37(2):105-10. PubMed ID: 2342627 [TBL] [Abstract][Full Text] [Related]
8. 9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine: a novel prodrug of 9-(2-phosphonylmethoxyethyl)guanine with improved antitumor efficacy and selectivity in choriocarcinoma-bearing rats. Naesens L; Hatse S; Segers C; Verbeken E; De Clercq E; Waer M; Balzarini J Oncol Res; 1999; 11(4):195-203. PubMed ID: 10566618 [TBL] [Abstract][Full Text] [Related]
9. 9-(2-phosphonylmethoxyethyl) derivatives of purine nucleotide analogs: A comparison of their metabolism and interaction with cellular DNA synthesis. Kramata P; Downey KM Mol Pharmacol; 1999 Dec; 56(6):1262-70. PubMed ID: 10570054 [TBL] [Abstract][Full Text] [Related]
10. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates. Aduma P; Connelly MC; Srinivas RV; Fridland A Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743 [TBL] [Abstract][Full Text] [Related]
11. 9-(2-Phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG). Compton ML; Toole JJ; Paborsky LR Biochem Pharmacol; 1999 Aug; 58(4):709-14. PubMed ID: 10413310 [TBL] [Abstract][Full Text] [Related]
12. Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Holý A; Votruba I; Merta A; Cerný J; Veselý J; Vlach J; Sedivá K; Rosenberg I; Otmar M; Hrebabecký H Antiviral Res; 1990 Jun; 13(6):295-311. PubMed ID: 1699493 [TBL] [Abstract][Full Text] [Related]
13. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2). Annaert P; Kinget R; Naesens L; de Clercq E; Augustijns P Pharm Res; 1997 Apr; 14(4):492-6. PubMed ID: 9144737 [TBL] [Abstract][Full Text] [Related]
14. Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells. Robbins BL; Greenhaw J; Connelly MC; Fridland A Antimicrob Agents Chemother; 1995 Oct; 39(10):2304-8. PubMed ID: 8619586 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine by AMP(dAMP) kinase from L1210 cells. Merta A; Votruba I; Jindrich J; Holý A; Cihlár T; Rosenberg I; Otmar M; Herve TY Biochem Pharmacol; 1992 Nov; 44(10):2067-77. PubMed ID: 1449524 [TBL] [Abstract][Full Text] [Related]
16. Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo. Naesens L; Balzarini J; De Clercq E Antiviral Res; 1991 Jul; 16(1):53-64. PubMed ID: 1776876 [TBL] [Abstract][Full Text] [Related]
17. 5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives. Balzarini J; De Clercq E J Biol Chem; 1991 May; 266(14):8686-9. PubMed ID: 1851154 [TBL] [Abstract][Full Text] [Related]
18. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine. Naesens L; Balzarini J; Bischofberger N; De Clercq E Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. Dallas S; Schlichter L; Bendayan R J Pharmacol Exp Ther; 2004 Jun; 309(3):1221-9. PubMed ID: 14762102 [TBL] [Abstract][Full Text] [Related]
20. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine. Guo Y; Kotova E; Chen ZS; Lee K; Hopper-Borge E; Belinsky MG; Kruh GD J Biol Chem; 2003 Aug; 278(32):29509-14. PubMed ID: 12764137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]